Clinical Trial Update: Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney Failure [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating nesiritide (BNP) for kidney function in patients with congestive heart failure and renal failure was terminated, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiorenal Syndrome
• Heart Failure
• Renal Failure

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: Horng Chen | Conditions: Cardiorenal Syndrome | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2012-10-17